' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review.
Zehentmayr, F; Grambozov, B; Kaiser, J; Fastner, G; Sedlmayer, F;
Thorac Cancer. 2020; 11(6): 137-1385.


Fastner Gerd
Grambozov Brane
Kaiser Julia
Sedlmayer Felix
Zehentmayr Franz


Concomitant chemo-radiotherapy (cCRT) with 60 Gy in 30 fractions is the standard of care for stage 111 non-small cell lung cancer (NSCLC). With a median overall survival of 28.7 months at best and maximum locoregional control rates of 70% at two years, the prognosis for these patients is still dismal. This systematic review summarizes data on dose escalation by alternative fractionation, which has been explored as a primary strategy to improve both local control and overall survival over the past three decades. A Pubmed literature search was performed according to the PRISMA guidelines. Because of the large variety of radiation regimens total doses were converted to EQD

Find related publications in this database (Keywords)

Acute esophagitis
modified fractionation
radiation dose escalation
systematic review